Connecting to LinkedIn...

W1siziisijiwmtuvmdqvmtuvmdgvntqvmzgvnzi1l01ptlrbu0hfqkxpr19vtljftkrfukvex0lnqudfx3jlc2l6zwrfyw5kx3jlbmrlcmvklmpwzyjdlfsiccisinrodw1iiiwimtkymhgxmjuwiyjdxq

Blog

GSK in $350 million deal to develop cancer drugs with UK biotech firm: FT

2/06/2014 by

W1siziisijiwmtqvmtavmjgvmtuvmzkvntgvntq5l2zpbguixsxbinailcj0ahvtyiisijywmhg0mdbcdtawm2uixv0

GlaxoSmithKline Plc has agreed a deal worth more than $350 million with UK biotech company Adaptimmune to develop cancer drugs, the Financial Times reported on Monday.

London-based GSK, which sold its cancer drugs business to Swiss drugmaker Novartis in April, is expected to announce the deal on Monday, according to an FT report.

The newspaper said that GSK would pay Adaptimmune as much as $350 million over the next seven years, subject to development milestones being met.

Further payments would be due in subsequent years if GSK exercises all its options and targets continue to be met. In addition, Adaptimmune would receive sales royalties on any products that reach market, the financial daily reported.

The newspaper said GSK would develop cell-based cancer therapies that involve re-engineering patients’ white blood cells to improve the body’s ability to fight tumors.

The FT quoted James Noble, chief executive of Adaptimmune, as saying that the development work would be done at the company’s laboratories in Oxfordshire – boosting efforts to promote the so-called “golden triangle” around Oxford, Cambridge and London as a globally competitive biotech hub.

This article has been extracted from http://news.yahoo.com, please click on this link to read the article in full http://news.yahoo.com/gsk-350-million-deal-develop-cancer-drugs-uk-235742780–finance.html

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

comments powered by Disqus

Social Stream

Latest News

W1siziisijiwmtcvmdqvmjqvmtqvmzqvmzuvnjg3l3nodxr0zxjzdg9ja182mdq2otc5nziuanbnil0swyjwiiwidgh1bwiilcizodb4mtawiyjdxq

What Does A Snap Election Mean For Recruitment?

2017-04-25 08:00:00 +0100

On Tuesday 18th April, Prime Minister Theresa May called a snap general election for 8th June, taking the nation by surprise. Rather than waiting until 2020, voters will now be casting their ballots in a matter of weeks. The hope for the government is that a Tory victory give the prime minister a strong mandate in parliament as Brexit negotiations begin. This sudden decision has been embraced by many in the recruitment industry due to the anticipated st...

W1siziisijiwmtcvmdqvmtkvmtuvndivntgvnjcyl3nodxr0zxjzdg9ja18xmja3mdi1ndcuanbnil0swyjwiiwidgh1bwiilcizodb4mtawiyjdxq

Evolve or Die: The Importance of Being Agile

2017-04-19 18:00:00 +0100

In the high-speed world of IT, agility is essential if you want to stay on top. Over the last 20 years, Montash Managing Director Roy Dungworth has experienced many changes in the industry. But two things never change - the need for business agility and the importance of people. Roy shares his insights after two decades in the industry. The pace of the IT industry increases every year. The way people buy or consume information today is having an enormou...